258 related articles for article (PubMed ID: 2846825)
41. Regulation of multiple forms of cyclic nucleotide phosphodiesterase from bovine hypothalamus: new factors modulating enzyme activity.
Galoyan AA; Gurvitz BYa
Neurochem Res; 1985 Nov; 10(11):1467-81. PubMed ID: 3003614
[TBL] [Abstract][Full Text] [Related]
42. Prevention by phosphodiesterase inhibitors of antigen-induced contraction of guinea-pig colonic smooth muscle.
Grous M; Barnette M
Br J Pharmacol; 1994 Jan; 111(1):259-63. PubMed ID: 7516803
[TBL] [Abstract][Full Text] [Related]
43. Oocyte maturation involves compartmentalization and opposing changes of cAMP levels in follicular somatic and germ cells: studies using selective phosphodiesterase inhibitors.
Tsafriri A; Chun SY; Zhang R; Hsueh AJ; Conti M
Dev Biol; 1996 Sep; 178(2):393-402. PubMed ID: 8812137
[TBL] [Abstract][Full Text] [Related]
44. Involvement of rolipram-sensitive cyclic AMP phosphodiesterase in the regulation of cardiac contraction.
Muller B; Lugnier C; Stoclet JC
J Cardiovasc Pharmacol; 1990 Nov; 16(5):796-803. PubMed ID: 1703603
[TBL] [Abstract][Full Text] [Related]
45. Correlation of cell-free brain cyclic nucleotide phosphodiesterase activities to cyclic AMP decay in intact brain slices.
Whalin ME; Garrett RL; Thompson WJ; Strada SJ
Second Messengers Phosphoproteins; 1988-1989; 12(5-6):311-25. PubMed ID: 2856115
[TBL] [Abstract][Full Text] [Related]
46. Effect of isozyme-selective inhibitors of phosphodiesterase on histamine-stimulated cyclic AMP accumulation in guinea-pig hippocampus.
Stanley C; Brown AM; Hill SJ
J Neurochem; 1989 Mar; 52(3):671-6. PubMed ID: 2465375
[TBL] [Abstract][Full Text] [Related]
47. Insulin stimulation of cyclic AMP phosphodiesterase is independent from the G-protein pathways involved in adenylate cyclase regulation.
Weber HW; Chung FZ; Day K; Appleman MM
J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(5):345-54. PubMed ID: 3040818
[TBL] [Abstract][Full Text] [Related]
48. Role of hormone-sensitive low Km cAMP phosphodiesterase in regulation of cAMP-dependent protein kinase and lipolysis in rat adipocytes.
Smith CJ; Manganiello VC
Mol Pharmacol; 1989 Mar; 35(3):381-6. PubMed ID: 2538713
[TBL] [Abstract][Full Text] [Related]
49. Induction of apoptosis by an inhibitor of cAMP-specific PDE in malignant murine carcinoma cells overexpressing PDE activity in comparison to their nonmalignant counterparts.
Marko D; Romanakis K; Zankl H; Fürstenberger G; Steinbauer B; Eisenbrand G
Cell Biochem Biophys; 1998; 28(2-3):75-101. PubMed ID: 9515161
[TBL] [Abstract][Full Text] [Related]
50. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of neurally mediated nonadrenergic, noncholinergic contractions of guinea pig bronchus by isozyme-selective phosphodiesterase inhibitors.
Undem BJ; Meeker SN; Chen J
J Pharmacol Exp Ther; 1994 Nov; 271(2):811-7. PubMed ID: 7965800
[TBL] [Abstract][Full Text] [Related]
52. Early increase in lymphocyte cyclic nucleotide phosphodiesterase activity upon mitogenic activation of human peripheral blood mononuclear cells.
Meskini N; Hosni M; Nemoz G; Lagarde M; Prigent AF
J Cell Physiol; 1992 Jan; 150(1):140-8. PubMed ID: 1309823
[TBL] [Abstract][Full Text] [Related]
53. Role of selective cyclic GMP phosphodiesterase inhibition in the myorelaxant actions of M&B 22,948, MY-5445, vinpocetine and 1-methyl-3-isobutyl-8-(methylamino)xanthine.
Souness JE; Brazdil R; Diocee BK; Jordan R
Br J Pharmacol; 1989 Nov; 98(3):725-34. PubMed ID: 2480168
[TBL] [Abstract][Full Text] [Related]
54. Effects of zaprinast and rolipram on platelet aggregation and arrhythmias following myocardial ischaemia and reperfusion in anaesthetized rabbits.
Holbrook M; Coker SJ
Br J Pharmacol; 1991 Aug; 103(4):1973-9. PubMed ID: 1655149
[TBL] [Abstract][Full Text] [Related]
55. Role of phosphodiesterase isoenzymes in regulating intracellular cyclic AMP in adenosine-stimulated smooth muscle cells.
Xiong Y; Westhead EW; Slakey LL
Biochem J; 1995 Jan; 305 ( Pt 2)(Pt 2):627-33. PubMed ID: 7832782
[TBL] [Abstract][Full Text] [Related]
56. Hormone-sensitive cyclic GMP-inhibited cyclic AMP phosphodiesterase in rat adipocytes. Regulation of insulin- and cAMP-dependent activation by phosphorylation.
Smith CJ; Vasta V; Degerman E; Belfrage P; Manganiello VC
J Biol Chem; 1991 Jul; 266(20):13385-90. PubMed ID: 1649189
[TBL] [Abstract][Full Text] [Related]
57. Isoprenaline induction of cAMP-phosphodiesterase in guinea-pig macrophages occurs in the presence, but not in the absence, of the phosphodiesterase type IV inhibitor rolipram.
Kochetkova M; Burns FM; Souness JE
Biochem Pharmacol; 1995 Dec; 50(12):2033-8. PubMed ID: 8849330
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of a phosphodiesterase III in the lysis-sensitive target-induced elevation of cyclic AMP (cAMP) in human natural killer cells.
Whalen MM; Crews JD
Biochem Pharmacol; 2000 Aug; 60(4):499-506. PubMed ID: 10874124
[TBL] [Abstract][Full Text] [Related]
59. Effects of solubilization and vanadate/glutathione complex on inhibitor potencies against eosinophil cyclic AMP-specific phosphodiesterase.
Souness JE; Maslen C; Scott LC
FEBS Lett; 1992 May; 302(2):181-4. PubMed ID: 1321725
[TBL] [Abstract][Full Text] [Related]
60. 8-(4-Chlorophenyl)thio-cyclic AMP is a potent inhibitor of the cyclic GMP-specific phosphodiesterase (PDE VA).
Connolly BJ; Willits PB; Warrington BH; Murray KJ
Biochem Pharmacol; 1992 Dec; 44(12):2303-6. PubMed ID: 1335252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
